Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Prima BioMed Ltd (IMMP) had Cash Flow from Financial Activities of $-0.28M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$113.21M |
|
$0.03M |
|
$5.58M |
|
$118.79M |
|
$6.00M |
|
-- |
|
$0.42M |
|
$6.42M |
|
$112.37M |
|
$107.30M |
|
$112.37M |
|
145.56M |
|
| Cash Flow Statement Financials | |
$-18.60M |
|
$-40.92M |
|
|
Cash Flow from Financial Activities |
$-0.28M |
$105.41M |
|
$48.14M |
|
$-57.27M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|